These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38552012)

  • 1. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases.
    Huang Q; Ru Y; Luo Y; Luo X; Liu D; Ma Y; Zhou X; Linghu M; Xu W; Gao F; Huang Y
    Sci Adv; 2024 Mar; 10(13):eadk1200. PubMed ID: 38552012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis.
    Li C; Wu Y; Chen K; Chen R; Xu S; Yang B; Lian Z; Wang X; Wang K; Xie H; Zheng S; Liu Z; Wang D; Xu X
    Cell Death Dis; 2023 Dec; 14(12):810. PubMed ID: 38065978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
    Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
    Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis.
    Shi L; Song Z; Li Y; Huang J; Zhao F; Luo Y; Wang J; Deng F; Shadekejiang H; Zhang M; Dong S; Wu X; Zhu J
    Am J Transplant; 2023 Jan; 23(1):11-25. PubMed ID: 36695612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
    Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
    Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
    Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
    Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury.
    Li Y; Cao Y; Xiao J; Shang J; Tan Q; Ping F; Huang W; Wu F; Zhang H; Zhang X
    Cell Death Differ; 2020 Sep; 27(9):2635-2650. PubMed ID: 32203170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.
    Sun Z; Wu J; Bi Q; Wang W
    Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis.
    Zhang F; Li Z; Gao P; Zou J; Cui Y; Qian Y; Gu R; Xu W; Hu J
    Front Pharmacol; 2022; 13():1024292. PubMed ID: 36483736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
    Jia B; Li J; Song Y; Luo C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
    Zhang HL; Hu BX; Li ZL; Du T; Shan JL; Ye ZP; Peng XD; Li X; Huang Y; Zhu XY; Chen YH; Feng GK; Yang D; Deng R; Zhu XF
    Nat Cell Biol; 2022 Jan; 24(1):88-98. PubMed ID: 35027735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
    Chen J; Yang L; Geng L; He J; Chen L; Sun Q; Zhao J; Wang X
    Front Cell Neurosci; 2021; 15():632354. PubMed ID: 33889074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
    Yu Q; Zhang N; Gan X; Chen L; Wang R; Liang R; Jian J
    Phytomedicine; 2023 Oct; 119():154999. PubMed ID: 37597361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis.
    Wei Z; Hang S; Wiredu Ocansey DK; Zhang Z; Wang B; Zhang X; Mao F
    J Nanobiotechnology; 2023 Jun; 21(1):188. PubMed ID: 37303049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway.
    Du YW; Li XK; Wang TT; Zhou L; Li HR; Feng L; Ma H; Liu HB
    Mol Med; 2023 Apr; 29(1):42. PubMed ID: 37013504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
    He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
    Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
    Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.
    Mishima E; Sato E; Ito J; Yamada KI; Suzuki C; Oikawa Y; Matsuhashi T; Kikuchi K; Toyohara T; Suzuki T; Ito S; Nakagawa K; Abe T
    J Am Soc Nephrol; 2020 Feb; 31(2):280-296. PubMed ID: 31767624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.